Dorzolamide Hydrochloride Solution/ Drops
Product Images NDC 62332-519

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride (NDC 62332-519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dorzolamide-bot-lab (Dorzolamide Bot Lab)

Label of Dorzolamide Hydrochloride Ophthalmic Solution USP 2% (20 mg/mL) in a 10 mL bottle. The label states Rx only, dosage form as ophthalmic solution, and includes storage instructions. Manufactured by Alembic Pharmaceuticals Inc., USA, and made in India. Bar code and NDC 62332-519-10 are visible.*

FDA Label Image

Dorzolamide-cart-lab (Dorzolamide Cart Lab)

Packaging label for Dorzolamide Hydrochloride Ophthalmic Solution USP 2%, 10 mL, from Alembic Pharmaceuticals Inc. The label features the product name, strength (20 mg/mL equivalent), sterile and Rx only indications, and directions for topical eye application. It includes storage information, inactive ingredients, and manufacturer details for Alembic Pharmaceuticals and Gland Pharma Limited, India. The label also shows batch coding, expiration, barcode, and sterility instructions.*

FDA Label Image

Dorzolamide-fig-a (Dorzolamide Fig A)

Illustration of a Dorzolamide Hydrochloride ophthalmic solution bottle showing labeled parts: cap, tamper evident ring, and bottle. The bottle is designed for the 20 mg/mL solution strength supplied by Alembic Pharmaceuticals Inc.*

FDA Label Image

Dorzolamide-fig-b (Dorzolamide Fig B)

An instructional illustration showing a dropper bottle with the cap partially unscrewed and rotated counterclockwise to remove it. The bottle appears designed for ophthalmic solution drops.*

FDA Label Image

Dorzolamide-fig-c (Dorzolamide Fig C)

An instructional illustration labeled Figure C showing a hand positioning a dropper to administer ophthalmic solution drops into an open eye. The drawing depicts the user holding the dropper above the eye for correct dosing.*

FDA Label Image

Dorzolamide-fig-d (Dorzolamide Fig D)

Illustration showing the proper technique for administering eye drops, with a hand holding a dropper bottle positioned above an open eye and a drop being applied to the eye.*

FDA Label Image

Dorzolamide-structure (Dorzolamide Structure)

Chemical structure diagram of Dorzolamide Hydrochloride, showing its molecular components including a sulfonamide group and hydrochloride association. The image depicts bonds, rings, and functional groups characteristic of the active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.